Epilepsy surgery in children under 3 years of age: surgical and developmental outcomes.


Journal

Journal of neurosurgery. Pediatrics
ISSN: 1933-0715
Titre abrégé: J Neurosurg Pediatr
Pays: United States
ID NLM: 101463759

Informations de publication

Date de publication:
13 Aug 2021
Historique:
received: 02 03 2021
accepted: 13 04 2021
pubmed: 14 8 2021
medline: 12 11 2021
entrez: 13 8 2021
Statut: epublish

Résumé

Pediatric epilepsy surgery is known to be effective, but early surgery in infancy is not well characterized. Extensive cortical dysplasia, such as hemimegalencephaly, can cause refractory epilepsy shortly after birth, and early surgical intervention is indicated. However, the complication rate of early pediatric surgery is significant. In this study, the authors assessed the risk-benefit balance of early pediatric epilepsy surgery as relates to developmental outcomes. This is a retrospective descriptive study of 75 patients who underwent their first curative epilepsy surgery at an age under 3 years at the authors' institution between 2006 and 2019 and had a minimum 1-year follow-up of seizure and developmental outcomes. Clinical information including surgical complications, seizure outcomes, and developmental quotient (DQ) was collected from medical records. The effects of clinical factors on DQ at 1 year after surgery were evaluated. The median age at surgery was 6 months, peaking at between 3 and 4 months. Operative procedures included 27 cases of hemispherotomy, 19 cases of multilobar surgery, and 29 cases of unilobar surgery. Seizure freedom was achieved in 82.7% of patients at 1 year and in 71.0% of patients at a mean follow-up of 62.8 months. The number of antiseizure medications (ASMs) decreased significantly after surgery, and 19 patients (30.6%) had discontinued their ASMs by the last follow-up. Postoperative complications requiring cerebrospinal fluid (CSF) diversion surgery, such as hydrocephalus and cyst formation, were observed in 13 patients (17.3%). The mean DQ values were 74.2 ± 34.3 preoperatively, 60.3 ± 23.3 at 1 year after surgery, and 53.4 ± 25.1 at the last follow-up. Multiple regression analysis revealed that the 1-year postoperative DQ was significantly influenced by preoperative DQ and postoperative seizure freedom but not by the occurrence of any surgical complication requiring CSF diversion surgery. Early pediatric epilepsy surgery has an acceptable risk-benefit balance. Seizure control after surgery is important for postoperative development.

Identifiants

pubmed: 34388720
doi: 10.3171/2021.4.PEDS21123
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

395-403

Auteurs

Masaki Iwasaki (M)

1Department of Neurosurgery, National Center Hospital, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo.

Keiya Iijima (K)

1Department of Neurosurgery, National Center Hospital, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo.

Takahiro Kawashima (T)

2Department of Clinical Epidemiology, Translational Medical Center, NCNP, Kodaira, Tokyo.

Hisateru Tachimori (H)

2Department of Clinical Epidemiology, Translational Medical Center, NCNP, Kodaira, Tokyo.

Yutaro Takayama (Y)

1Department of Neurosurgery, National Center Hospital, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo.

Yuiko Kimura (Y)

1Department of Neurosurgery, National Center Hospital, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo.

Yuu Kaneko (Y)

1Department of Neurosurgery, National Center Hospital, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo.

Naoki Ikegaya (N)

3Department of Neurosurgery, Yokohama City University Hospital, Yokohama, Kanagawa.

Noriko Sumitomo (N)

4Department of Child Neurology, National Center Hospital, NCNP, Kodaira, Tokyo.

Takashi Saito (T)

4Department of Child Neurology, National Center Hospital, NCNP, Kodaira, Tokyo.

Eiji Nakagawa (E)

4Department of Child Neurology, National Center Hospital, NCNP, Kodaira, Tokyo.

Akio Takahashi (A)

5Department of Neurosurgery, Shibukawa Medical Center, Shibukawa, Gunma; and.

Kenji Sugai (K)

4Department of Child Neurology, National Center Hospital, NCNP, Kodaira, Tokyo.

Taisuke Otsuki (T)

6Epilepsy Centre Bethel Japan, Iwanuma, Miyagi, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH